Clinical Trial Update: Evaluation of Long-term Safety in Parkinsonian Patients With Intracerebroventricular Administration of A-dopamine (Anaerobic Dopamine) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating long-term safety of intracerebroventricular A-dopamine in Parkinson disease patients; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• A-dopamine (Anaerobic Dopamine) (A-dopamine)

Snippet

Sponsor: University Hospital, Lille | Conditions: Parkinson Disease | Phase 1, Phase 2 | Status: RECRUITING